IHOP osteoporosis


or prostate cancer.
Mincey BA1, Tan WW.
Author information
Abstract
Osteoporosis is a disease that is associated with significant morbidity and mortality, much of which can be prevented with available therapy. The risk for osteoporosis is increased in individuals with some types of cancer, especially in women with breast cancer and men with prostate cancer. This is caused by several factors, including premature ovarian failure and systemic antihormonal therapy in women, androgen ablation therapy in men, and potential direct effects of chemotherapy and of cancer on bone metabolism. With continual increases in the incidence of breast cancer, earlier detection and treatment, and improvements in survival for both patients with breast and prostate cancer, the importance of appropriate screening for and management of osteoporosis is evident. We review the evidence supporting an increased risk for development of osteoporosis in individuals with breast or prostate cancer, and strategies for prevention and treatment of osteoporosis in these patients.
PMID: 18628136 [PubMed]
Share on FacebookShare on TwitterShare on Google+

Advertisements

About garyskeete

ASHWORTH MEDICINE-Professional Medical Assisting, Doctor of Science,Legal Assistant Diploma BSc Criminal Justice
This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s